Martin Huber
Corporate Officer/Principal bij NAUTILUS BIOTECHNOLOGY, INC.
Actieve functies van Martin Huber
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| NAUTILUS BIOTECHNOLOGY, INC. | Corporate Officer/Principal | 01-11-2023 | - |
Loopbaan van Martin Huber
Eerdere bekende functies van Martin Huber
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Quantapore, Inc.
 Quantapore, Inc. BiotechnologyHealth Technology Quantapore, Inc. develops nanopore based nucleic acid sequencing technology products. The firm's proprietary DNA sequencing technology is based on an optically labeled nanopore which interacts via energy transfer with a labeled nucleic acid sample. The company was founded by Martin Huber and Sascha C. Dennstedt in 2009 and is headquartered in Menlo Park, CA. | Directeur/Bestuurslid | 01-01-2009 | - |
| Algemeen Directeur | 01-01-2009 | - | |
| Oprichter | 01-01-2009 | - |
Opleiding van Martin Huber
| University of Vienna | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 3 |
| Oostenrijk | 2 |
Operationeel
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
| Founder | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| NAUTILUS BIOTECHNOLOGY, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Quantapore, Inc.
Quantapore, Inc. BiotechnologyHealth Technology Quantapore, Inc. develops nanopore based nucleic acid sequencing technology products. The firm's proprietary DNA sequencing technology is based on an optically labeled nanopore which interacts via energy transfer with a labeled nucleic acid sample. The company was founded by Martin Huber and Sascha C. Dennstedt in 2009 and is headquartered in Menlo Park, CA. | Health Technology |
- Beurs
- Insiders
- Martin Huber
- Ervaring